SCHEMBL4907706

SCHEMBL4907706

O=C(NCc1c(Cl)c(Cl)nc(Cl)c1Cl)c1cnccc1C(F)(F)F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.54
POLB P06746 2/20 0.53
NPC1 O15118 2/20 0.53
DGAT2 Q96PD7 1/20 0.45
CNR2 P34972 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAPT P10636 2/20 0.39
SORT1 Q99523 2/20 0.38
HTT P42858 1/20 0.38
MCHR1 Q99705 1/20 0.38
CSNK1D P48730 1/20 0.37
CSNK1E P49674 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
TRPV1 Q8NER1 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
CASP1 P29466 1/20 0.37
DHODH Q02127 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4916272 0.81 ALDH1A1 (0.56) ALDH1A1POLBNPC1DGAT2CNR2
SCHEMBL15236978 0.80 POLB (0.65) ALDH1A1POLBNPC1CNR2CYP1A2
SCHEMBL27335141 0.79 ALDH1A1 (0.59) ALDH1A1POLBNPC1DGAT2MAPT
SCHEMBL4914157 0.79 ALDH1A1 (0.57) ALDH1A1POLBNPC1DGAT2CNR2
SCHEMBL4908836 0.79 ALDH1A1 (0.54) ALDH1A1POLBNPC1DGAT2CNR2
SCHEMBL4914815 0.78 ALDH1A1 (0.53) ALDH1A1POLBNPC1DGAT2CNR2
SCHEMBL8569196 0.78 ALDH1A1 (0.61) ALDH1A1POLBNPC1DGAT2MAPT
SCHEMBL3762834 0.77 ALDH1A1 (0.60) ALDH1A1POLBNPC1DGAT2MAPT
SCHEMBL4916519 0.77 ALDH1A1 (0.53) ALDH1A1POLBNPC1DGAT2CNR2
SCHEMBL4914769 0.77 ALDH1A1 (0.55) ALDH1A1POLBNPC1DGAT2CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293674-A1 Azinyl Imidazoazine and Azinyl Carboxamide BAYER CROPSCIENCE AG (DE) 2008-11-27 US claimed
CN-1980926-A Azinyl imidazoazine and azinyl carboxamide BAYER CROPSCIENCE AG (DE) 2007-06-13 CN claimed
EP-1751152-A2 AZINYL IMIDAZOAZINE AND AZINYL CARBOXAMIDE Bayer CropScience Aktiengesellschaft (DE) 2007-02-14 EP claimed
WO-2005113553-A2 AZINYL IMIDAZOAZINE AND AZINYL CARBOXAMIDE BAYER CROPSCIENCE AG (DE) 2005-12-01 WO claimed
US-20080293674-A1 Azinyl Imidazoazine and Azinyl Carboxamide BAYER CROPSCIENCE AG (DE) 2008-11-27 US disclosed
CN-1980926-A Azinyl imidazoazine and azinyl carboxamide BAYER CROPSCIENCE AG (DE) 2007-06-13 CN disclosed
EP-1751152-A2 AZINYL IMIDAZOAZINE AND AZINYL CARBOXAMIDE Bayer CropScience Aktiengesellschaft (DE) 2007-02-14 EP disclosed
WO-2005113553-A2 AZINYL IMIDAZOAZINE AND AZINYL CARBOXAMIDE BAYER CROPSCIENCE AG (DE) 2005-12-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293674-A1 Azinyl Imidazoazine and Azinyl Carboxamide AZI2, NISCH, ZYX ALDH1A1 1233/4885POLB 3655/4885NPC1 2845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.